Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity. (14th September 2022)

• Record Type: Journal Article
• Authors: Pogostin, Brett H.; Yu, Marina H.; Azares, Alon R.; Euliano, Erin M.; Lai, Cheuk Sun Edwin; Saenz, Gabriel; Wu, Samuel X.; Farsheed, Adam C.; Melhorn, Sarah M.; Graf, Tyler P.; Woodside, Darren G.; Hartgerink, Jeffrey D.; McHugh, Kevin J.
• Is Part Of: Biomaterials science. Volume 10:Number 21(2022)
• Page Start: 6217
• Page End: 6229
• Publication Date: 2022-09-14
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d2bm01242a
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : Self-assembling multidomain peptide hydrogels direct a nearly exclusive humoral adaptive immune response compared to alum, the most widely used adjuvant in vaccines. Abstract : Adjuvants play a critical role in enhancing vaccine efficacy; however, there is a need to develop new immunomodulatory compounds to address emerging pathogens and to expand the use of immunotherapies. Multidomain peptides (MDPs) are materials composed of canonical amino acids that form injectable supramolecular hydrogels under physiological salt and pH conditions. MDP hydrogels are rapidly infiltrated by immune cells in vivo and have previously been shown to influence cytokine production. Therefore, we hypothesized that these immunostimulatory characteristics would allow MDPs to function as vaccine adjuvants. Herein, we demonstrate that loading antigen into MDP hydrogels does not interfere with their rheological properties and that positively charged MDPs can act as antigen depots, as demonstrated by their ability to release ovalbumin (OVA) over a period of 7–9 days in vivo . Mice vaccinated with MDP-adjuvanted antigen generated significantly higher IgG titers than mice treated with the unadjuvanted control, suggesting that these hydrogels potentiate humoral immunity. Interestingly, MDP hydrogels did not elicit a robust cellular immune response, as indicated by the lower production of IgG2c and smaller populations of tetramer-positive CD8 + T splenocytes compared to mice vaccinated alum-adjuvanted OVA. Together, the data suggest that MDP hydrogel adjuvants strongly bias the immune response towards humoral immunity while evoking a very limited cellular immune response. As a result, MDPs may have the potential to serve as adjuvants for applications that benefit exclusively from humoral immunity.